Cannabinoid-1 receptor antagonist rimonabant (SR141716) increases striatal dopamine D2 receptor availability

C.L. Crunelle, E. van der Giessen, S. Schulz, L.J.M.J. Vanderschuren, K. de Bruin, W. van den Brink, J. Booij

    Research output: Contribution to journalArticleAcademicpeer-review

    Original languageUndefined/Unknown
    Pages (from-to)908-911
    Number of pages4
    JournalAddiction Biology
    Volume18
    Issue number6
    DOIs
    Publication statusPublished - 2013

    Keywords

    • Econometric and Statistical Methods: General
    • Geneeskunde (GENK)
    • Geneeskunde(GENK)
    • Medical sciences
    • Bescherming en bevordering van de menselijke gezondheid

    Cite this